Cambridge Cognition, Ivory Team Up to Scale Early Cognitive Screening in India

Ivory plans to deploy CANTAB Pathway across its clinical network, consumer platform, and hospital and diagnostic partnerships.

Cambridge Cognition, a neuroscience technology company specialising in digital cognitive assessments, has partnered with Indian brain health startup Ivory to commercialise the CANTAB Pathway across professional healthcare and consumer health markets in India.

The partnership targets early identification of cognitive impairment, a growing public health concern. India’s population of 1.47 billion includes approximately 138 million people over the age of 60, of whom up to 34 million may be living with mild or major cognitive impairment, according to recent studies.

With no definitive cure for neurodegenerative conditions such as dementia, early detection and preventive intervention are increasingly critical.

Rob Baker, CEO of Cambridge Cognition, said, “India represents a major opportunity, with a significant unmet need for earlier identification of cognitive impairment. As health-conscious, tech-enabled populations grow, demand for proactive brain health tools is increasing rapidly. We are excited to partner with Ivory to expand access to CANTAB Pathway™ in India.”

Ivory, which recently published India’s first Brain Health Report, plans to deploy CANTAB Pathway across its clinical network, consumer platform, and hospital and diagnostic partnerships.

Assessments are currently available in English and multiple Indian languages, including Hindi, Tamil, Telugu, Bengali, and Kannada, with further language expansion planned.

Issac John, CEO of Ivory, added, “The Cambridge Cognition team have built CANTAB Pathway™ to be exactly the product we need to shift the focus from late-stage diagnosis to proactive brain health solutions.”

Clinical experts emphasised the benefits of early, scalable screening. Dr. Sumiti Saharan, Chief Scientific Officer at Ivory, said, “Underdiagnosis of cognitive impairment remains a significant gap in India. Validated digital tools such as CANTAB Pathway™ enable earlier identification and empower clinicians to intervene when it can make the greatest difference.”

Stay tuned for more such updates on Digital Health News